Skip to main content

Research Repository

Advanced Search

Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group

Berthelsen, Dorthe B.; Simon, Lee S.; Ioannidis, John P.A.; Voshaar, Marieke; Richards, Pam; Goel, Niti; Strand, Vibeke; Nielsen, Sabrina M.; Shea, Beverly J.; Tugwell, Peter; Bartlett, Susan J.; Hazlewood, Glen S.; March, Lyn; Singh, Jasvinder A.; Suarez-Almazor, Maria E.; Boers, Maarten; Stevens, Randall M.; Furst, Daniel E.; Woodworth, Thasia; Leong, Amye; Brooks, Peter M.; Flurey, Caroline; Christensen, Robin

Authors

Dorthe B. Berthelsen

Lee S. Simon

John P.A. Ioannidis

Marieke Voshaar

Pam Richards

Niti Goel

Vibeke Strand

Sabrina M. Nielsen

Beverly J. Shea

Peter Tugwell

Susan J. Bartlett

Glen S. Hazlewood

Lyn March

Jasvinder A. Singh

Maria E. Suarez-Almazor

Maarten Boers

Randall M. Stevens

Daniel E. Furst

Thasia Woodworth

Amye Leong

Peter M. Brooks

Profile Image

Caroline Flurey Caroline2.Flurey@uwe.ac.uk
Associate Professor in Men's Health and Long-term Conditions

Robin Christensen



Abstract

Objectives: To develop an understanding of the concept of safety/harms experienced by patients involved in clinical trials for their rheumatic and musculoskeletal diseases (RMDs) and to seek input from the OMERACT community before moving forward to developing or selecting an outcome measurement instrument. Methods: OMERACT 2023 presented and discussed interview results from 34 patients indicating that up to 171 items might be important for patients’ harm-reporting. Results: Domain was defined in detail and supported by qualitative work. Participants in the Special-Interest-Group endorsed (96 %) that enough qualitative data are available to start Delphi survey(s). Conclusion: We present a definition of safety/harms that represents the patient voice (i.e., patients’ perception of safety) evaluating the symptomatic treatment-related adverse events for people with RMDs enrolled in clinical trials.

Citation

Berthelsen, D. B., Simon, L. S., Ioannidis, J. P., Voshaar, M., Richards, P., Goel, N., …Christensen, R. (2023). Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group. Seminars in Arthritis and Rheumatism, 63, Article 152288. https://doi.org/10.1016/j.semarthrit.2023.152288

Journal Article Type Article
Acceptance Date Oct 25, 2023
Online Publication Date Oct 26, 2023
Publication Date Dec 31, 2023
Deposit Date Nov 19, 2023
Publicly Available Date Oct 27, 2024
Journal Seminars in Arthritis and Rheumatism
Print ISSN 0049-0172
Electronic ISSN 1532-866X
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 63
Article Number 152288
DOI https://doi.org/10.1016/j.semarthrit.2023.152288
Public URL https://uwe-repository.worktribe.com/output/11409112